THU-382 Lead-in cohort results from a phase 2 study of a novel 8-week combination regimen of Bemnifosbuvir and Ruzasvir in patients with chronic hepatitis C virus infection
Saved in:
Published in | Journal of hepatology Vol. 80; p. S819 |
---|---|
Main Authors | , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Elsevier B.V
01.06.2024
|
Online Access | Get full text |
Cover
Loading…
ISSN: | 0168-8278 1600-0641 |
---|---|
DOI: | 10.1016/S0168-8278(24)02257-8 |